Tom Hulick, CEO of Strategy Asset Managers, joined Schwab Network’s Morning Trade Live with Sam Vadas to discuss Eli Lilly’s leadership in the weight-loss space and the evolving impact of healthcare innovation on the broader economy.
During the segment, Tom highlighted Lilly’s next-generation weight-loss treatments and discussed how improved health outcomes could contribute to increased productivity, consumer spending, and longer-term economic benefits. The conversation reinforced the importance of innovation-driven growth and SAM’s focus on identifying durable investment opportunities aligned with long-term societal trends.
No rush at all on the media posts—we’re flexible on timing there. And yes, taking another look at the team members afterward sounds great.
Thanks again, Sebastian. We really appreciate your responsiveness and support.